Literature DB >> 17929308

Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium.

Patricia A DeRusso1, Wen Ye, Ross Shepherd, Barbara A Haber, Benjamin L Shneider, Peter F Whitington, Kathleen B Schwarz, Jorge A Bezerra, Philip Rosenthal, Saul Karpen, Robert H Squires, John C Magee, Patricia R Robuck, Ronald J Sokol.   

Abstract

UNLABELLED: Malnutrition is a significant clinical problem in infants with biliary atresia. The natural history of poor growth and its potential association with early transplantation or death in children with biliary atresia was determined. Serial weight- and length-for-age z-scores were computed as part of a retrospective study of 100 infants who underwent hepatoportoenterostomy (HPE) for biliary atresia at 9 U.S. pediatric centers between 1997 and 2000. Poor outcome was defined as transplantation or death by 24 months of age (n = 46) and good outcome was defined as survival with native liver at 24 months of age with total serum bilirubin less than 6 mg/dL (n = 54). Growth velocity was significantly slower in the poor outcome group compared to the good outcome group (P < 0.001 for both weight and length). Mean weight z-scores were significantly lower by 6 months after HPE in the poor outcome group (-2.1 +/- 1.4) compared to the good outcome group (-1.2 +/- 1.4) (P < 0.001). In a subgroup with total bilirubin between 2 and 6 mg/dL at 3 months after HPE (n = 28), the weight z-scores at 3 months after HPE were significantly lower in the poor outcome group (-2.0 +/-1.2) compared to the good outcome group (-1.0 +/- 1.2) (P = 0.04) despite similar bilirubin concentrations.
CONCLUSION: Growth failure after HPE was associated with transplantation or death by 24 months of age. The combination of intermediate bilirubin concentrations and poor mean weight z-scores 3 months after HPE was also associated with poor clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17929308      PMCID: PMC3881187          DOI: 10.1002/hep.21923

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Early prediction of long-term survival and the timing of liver transplantation after the Kasai operation.

Authors:  Y Ohhama; M Shinkai; S Fujita; T Nishi; H Yamamoto
Journal:  J Pediatr Surg       Date:  2000-07       Impact factor: 2.545

Review 2.  Extrahepatic biliary atresia: a disease or a phenotype?

Authors:  David H Perlmutter; Ross W Shepherd
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

Review 3.  Pathogenesis and outcome of biliary atresia: current concepts.

Authors:  Ronald J Sokol; Cara Mack; Michael R Narkewicz; Frederick M Karrer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-07       Impact factor: 2.839

4.  Resting energy expenditure is increased in infants and children with extrahepatic biliary atresia.

Authors:  A Pierro; B Koletzko; V Carnielli; R A Superina; E A Roberts; R M Filler; J Smith; T Heim
Journal:  J Pediatr Surg       Date:  1989-06       Impact factor: 2.545

5.  Nasogastric feeding enhances nutritional status in paediatric liver disease but does not alter circulating levels of IGF-I and IGF binding proteins.

Authors:  R I Holt; J P Miell; J S Jones; G Mieli-Vergani; A J Baker
Journal:  Clin Endocrinol (Oxf)       Date:  2000-02       Impact factor: 3.478

6.  Pre-operative nutritional support in children with end-stage liver disease accepted for liver transplantation: an approach to management.

Authors:  S E Chin; R W Shepherd; G J Cleghorn; M Patrick; T H Ong; J Wilcox; S Lynch; R Strong
Journal:  J Gastroenterol Hepatol       Date:  1990 Sep-Oct       Impact factor: 4.029

7.  Body composition and components of energy expenditure in children with end-stage liver disease.

Authors:  Ristan Greer; Megan Lehnert; Peter Lewindon; Geoffrey J Cleghorn; Ross W Shepherd
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-03       Impact factor: 2.839

8.  Long-term survival following Kasai portoenterostomy: is chronic liver disease inevitable?

Authors:  Nedim Hadzić; Mark Davenport; Sarah Tizzard; Jeanette Singer; Edward R Howard; Giorgina Mieli-Vergani
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-10       Impact factor: 2.839

9.  Anthropometric evaluation of children with chronic liver disease.

Authors:  R J Sokol; C Stall
Journal:  Am J Clin Nutr       Date:  1990-08       Impact factor: 7.045

10.  Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation.

Authors:  Sue V McDiarmid; Ravinder Anand; Anne S Lindblad
Journal:  Transplantation       Date:  2002-07-27       Impact factor: 4.939

View more
  22 in total

1.  Newborn Screening for Biliary Atresia.

Authors:  Kasper S Wang
Journal:  Pediatrics       Date:  2015-12       Impact factor: 7.124

2.  The anatomic pattern of biliary atresia identified at time of Kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival.

Authors:  Riccardo Superina; John C Magee; Mary L Brandt; Patrick J Healey; Greg Tiao; Fred Ryckman; Frederick M Karrer; Kishore Iyer; Annie Fecteau; Karen West; R Cartland Burns; Alan Flake; Hanmin Lee; Jeff A Lowell; Pat Dillon; Paul Colombani; Richard Ricketts; Yun Li; Jeffrey Moore; Kasper S Wang
Journal:  Ann Surg       Date:  2011-10       Impact factor: 12.969

3.  Parenteral nutrition supplementation in biliary atresia patients listed for liver transplantation.

Authors:  Jillian S Sullivan; Shikha S Sundaram; Zhaoxing Pan; Ronald J Sokol
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

4.  Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation.

Authors:  Moreshwar S Desai; Shabier Zainuer; Curtis Kennedy; Debra Kearney; John Goss; Saul J Karpen
Journal:  Gastroenterology       Date:  2011-07-14       Impact factor: 22.682

5.  Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia.

Authors:  Benjamin L Shneider; John C Magee; Saul J Karpen; Elizabeth B Rand; Michael R Narkewicz; Lee M Bass; Kathleen Schwarz; Peter F Whitington; Jorge A Bezerra; Nanda Kerkar; Barbara Haber; Philip Rosenthal; Yumirle P Turmelle; Jean P Molleston; Karen F Murray; Vicky L Ng; Kasper S Wang; Rene Romero; Robert H Squires; Ronen Arnon; Averell H Sherker; Jeffrey Moore; Wen Ye; Ronald J Sokol
Journal:  J Pediatr       Date:  2015-12-24       Impact factor: 4.406

Review 6.  Recent developments in diagnostics and treatment of neonatal cholestasis.

Authors:  Amy G Feldman; Ronald J Sokol
Journal:  Semin Pediatr Surg       Date:  2020-07-23       Impact factor: 2.754

7.  Staging of biliary atresia at diagnosis by molecular profiling of the liver.

Authors:  Katie Moyer; Vivek Kaimal; Cristina Pacheco; Reena Mourya; Huan Xu; Pranavkumar Shivakumar; Ranajit Chakraborty; Marepalli Rao; John C Magee; Kevin Bove; Bruce J Aronow; Anil G Jegga; Jorge A Bezerra
Journal:  Genome Med       Date:  2010-05-13       Impact factor: 11.117

Review 8.  Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care.

Authors:  Shikha S Sundaram; Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Liver Transpl       Date:  2017-01       Impact factor: 5.799

Review 9.  Beyond the Pediatric end-stage liver disease system: solutions for infants with biliary atresia requiring liver transplant.

Authors:  Mary Elizabeth M Tessier; Sanjiv Harpavat; Ross W Shepherd; Girish S Hiremath; Mary L Brandt; Amy Fisher; John A Goss
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium.

Authors:  Vicky Lee Ng; Barbara H Haber; John C Magee; Alexander Miethke; Karen F Murray; Sonia Michail; Saul J Karpen; Nanda Kerkar; Jean P Molleston; Rene Romero; Philip Rosenthal; Kathleen B Schwarz; Benjamin L Shneider; Yumirle P Turmelle; Estella M Alonso; Averell H Sherker; Ronald J Sokol
Journal:  J Pediatr       Date:  2014-07-09       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.